Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03854903
Brief Title: WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

First Submitted : February 21, 2019
First Submitted that Met QC Criteria : February 25, 2019
First Posted : February 26, 2019

Last Update Submitted that Met QC Criteria : April 1, 2020
Last Update Posted : April 2, 2020